Stock Events

Stock Events

KalVista Pharmaceuticals (4XC1.STU) Q1 2026 Earnings

25MarConfirmed

Q4 2025

Q1 2026

-0.8

-0.67

-0.55

-0.42

Details

Expected EPS

-0.58147875222

Actual EPS

-0.4238549

Surprise EPS

0.16

Surprise Percent

+27.11%

Description

KalVista Pharmaceuticals (4XC1.STU) has reported earnings of -0.4238549 per share for Q1 2026.

0 Comments

Share your thoughts

Get the Stock Events App

Sign up for a Stock Events account to create your own watchlists and track your portfolio or dividends.